BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36786033)

  • 1. Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.
    Nyström H; Jönsson M; Nilbert M; Carneiro A
    Acta Oncol; 2023 Jan; 62(1):33-39. PubMed ID: 36786033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognostic factors of T1 (≤5 cm) soft tissue sarcoma -- a comparative study with T2 (>5 cm) soft tissue sarcoma.
    Kang S; Han I; Lee S; Kim W; Kim H
    Eur J Surg Oncol; 2014 Apr; 40(4):406-11. PubMed ID: 24388741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas.
    Dancsok AR; Gao D; Lee AF; Steigen SE; Blay JY; Thomas DM; Maki RG; Nielsen TO; Demicco EG
    Oncoimmunology; 2020; 9(1):1747340. PubMed ID: 32313727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the tumor immune microenvironment in synovial sarcoma.
    Oike N; Kawashima H; Ogose A; Hotta T; Hatano H; Ariizumi T; Sasaki T; Yamagishi T; Umezu H; Endo N
    Cancer Sci; 2018 Oct; 109(10):3043-3054. PubMed ID: 30133055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of lymphocytes in soft tissue sarcomas.
    Sorbye SW; Kilvaer T; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
    PLoS One; 2011 Jan; 6(1):e14611. PubMed ID: 21298041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
    Rupp L; Resag A; Potkrajcic V; Warm V; Wehner R; Jöhrens K; Bösmüller H; Eckert F; Schmitz M
    Front Immunol; 2023; 14():1185197. PubMed ID: 37261361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma.
    Tsagozis P; Augsten M; Zhang Y; Li T; Hesla A; Bergh J; Haglund F; Tobin NP; Ehnman M
    Cancer Immunol Immunother; 2019 Jun; 68(6):927-936. PubMed ID: 30879106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.
    De La Motte Rouge T; Corné J; Cauchois A; Le Boulch M; Poupon C; Henno S; Rioux-Leclercq N; Le Pabic E; Laviolle B; Catros V; Levêque J; Fautrel A; Le Gallo M; Legembre P; Lavoué V
    Mol Cancer Res; 2019 Dec; 17(12):2537-2548. PubMed ID: 31537619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current soft-tissue sarcoma classifications.
    Daugaard S
    Eur J Cancer; 2004 Mar; 40(4):543-8. PubMed ID: 14962721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers.
    Ujiie H; Kadota K; Nitadori JI; Aerts JG; Woo KM; Sima CS; Travis WD; Jones DR; Krug LM; Adusumilli PS
    Oncoimmunology; 2015 Jun; 4(6):e1009285. PubMed ID: 26155428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas.
    Judge SJ; Bloomstein JD; Sholevar CJ; Darrow MA; Stoffel KM; Vick LV; Dunai C; Cruz SM; Razmara AM; Monjazeb AM; Rebhun RB; Murphy WJ; Canter RJ
    Front Immunol; 2022; 13():893177. PubMed ID: 35874727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20
    Sato J; Kitano S; Motoi N; Ino Y; Yamamoto N; Watanabe S; Ohe Y; Hiraoka N
    Cancer Sci; 2020 Jun; 111(6):1921-1932. PubMed ID: 32277550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of macrophage infiltration in leiomyosarcomas.
    Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
    Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
    Smolle MA; Herbsthofer L; Goda M; Granegger B; Brcic I; Bergovec M; Scheipl S; Prietl B; El-Heliebi A; Pichler M; Gerger A; Posch F; Tomberger M; López-García P; Feichtinger J; Baumgartner C; Leithner A; Liegl-Atzwanger B; Szkandera J
    Oncoimmunology; 2021 Mar; 10(1):1896658. PubMed ID: 33763294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors.
    Andersen LB; Nørgaard M; Rasmussen M; Fredsøe J; Borre M; Ulhøi BP; Sørensen KD
    J Pathol; 2021 Oct; 255(2):155-165. PubMed ID: 34255349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.